Journal profile · Medicine-Oncology
Clinical Medicine Insights-Oncology
ISSN 1179-5549 · Libertas Academica · ENGLAND
Clinical Medicine Insights-Oncology: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2.58; fully open access; APC about USD 2,650; median 147 days to acceptance (97 articles, last 24 months); acceptance rate 12.2% (journal website); 68 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Clinical Medicine Insights-Oncology is published by Libertas Academica and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Lung Cancer Treatments and Mutations, Cancer Immunotherapy and Biomarkers and Lung Cancer Research Studies, together about 24.2% of its articles. Its main subfields are Oncology and Pulmonary and Respiratory Medicine. (generated from OpenAlex topic counts and CAS ranking data)
Clinical Medicine Insights: Oncology is an international, peer-reviewed, open access journal that focuses on all aspects of cancer research and treatment, in addition to related genetic, pathophysiological and epidemiological topics. Of particular but not exclusive importance are molecular biology, clinical interventions, controlled trials, therapeutics, pharmacology and … | View full journal description This journal is a member of the Committee on Publication Ethics (COPE).
From the journal's Aims & Scope
Research area (LetPub): Medicine-Oncology
Editorial board by country: 35 in mainland China (about 21%); most named United States 46, Mainland China 35, Italy 23, Türkiye 12, India 7 (168 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Lung Cancer Treatments and MutationsMedicine9.1%
- Cancer Immunotherapy and BiomarkersMedicine8.3%
- Lung Cancer Research StudiesMedicine6.8%
- Colorectal Cancer Treatments and StudiesMedicine4.7%
- Inflammatory Biomarkers in Disease PrognosisMedicine4.7%
- Glioma Diagnosis and TreatmentMedicine4.1%
- Head and Neck Cancer StudiesMedicine4.1%
- Cancer Genomics and DiagnosticsBiochemistry, Genetics and Molecular Biology4.1%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Oncology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Oncology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Oncology | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.58LetPub ·
- Impact factor (publisher)
- 2.6Publisher website ·
- 5-year impact factor (publisher)
- 2.4Publisher website ·
- CiteScore 2026-06
- 3.5LetPub ·
- SJR 2026-06
- 0.65LetPub ·
- SNIP 2026-06
- 0.63LetPub ·
- h-index
- 43OpenAlex ·
- i10-index
- 227OpenAlex ·
- 2-year mean citedness
- 3.01OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 62LetPub ·
- Articles per year (publisher)
- 3Publisher website ·
Articles by year OpenAlex count · 618 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 50 | 50 | 6 |
| 2025 | 68 | 68 | 128 |
| 2024 | 80 | 80 | 461 |
| 2023 | 61 | 61 | 408 |
| 2022 | 68 | 68 | 598 |
| 2021 | 34 | 34 | 473 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
147 daysMedian, submission to acceptance · P25–P75 122 days – 190 days
- Acceptance to online
- median 30 days (97 articles)
- Submission to online
- median 182 days
- Sample
- 97 articles with submission and acceptance dates (149 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 8 weeksLetPub ·
- Acceptance rate (publisher)
- 12.2%Publisher website ·
- Submission to first decision
- 5 daysPublisher website ·
- Acceptance to publication
- 29 daysPublisher website ·
- Submission to publication (journal-reported)
- about 8 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 2,650 | Yes | CC BY, CC BY-NC | |
| OpenAlex | USD 2,650 | — | — | |
| LetPub | USD 2,650 | Yes | — | |
| Publisher website | USD 3,200 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare2 items from the author guidelines
- Reference style
- AMA
- Suggested reviewers
- Required
Article types accepted9
- meta-analyses4. Meta-analyses. These should answer a specific research question and be reported according to the PRISMA guidelines. They should also include a PRISMA flow ch…Length not stated
- meta-analysisView our Special Collections currently accepting submissions. Clinical Medicine Insights: Oncology considers the following kinds of article for publication: 1. …Length not stated
- original research articleView our Special Collections currently accepting submissions. Clinical Medicine Insights: Oncology considers the following kinds of article for publication: 1. …Length not stated
- protocolView our Special Collections currently accepting submissions. Clinical Medicine Insights: Oncology considers the following kinds of article for publication: 1. …Length not stated
- research articleView our Special Collections currently accepting submissions. Clinical Medicine Insights: Oncology considers the following kinds of article for publication: 1. …Length not stated
- reviewView our Special Collections currently accepting submissions. Clinical Medicine Insights: Oncology considers the following kinds of article for publication: 1. …Length not stated
- review articleView our Special Collections currently accepting submissions. Clinical Medicine Insights: Oncology considers the following kinds of article for publication: 1. …Length not stated
- study protocols5. Study Protocols. These can be for forthcoming or ongoing research. Information on trial registration (where applicable) and ethics approvalLength not stated
- systematic reviewView our Special Collections currently accepting submissions. Clinical Medicine Insights: Oncology considers the following kinds of article for publication: 1. …Length not stated
Policy excerpts from the journal's websiteAuthorship, Data availability, Publication ethics, Open access, Peer review, Plagiarism, Preprints, Trial registration / reporting guidelines
- Authorship Author contributions
You will be asked to list the contribution of each author as part of the submission process. Please include the Author Contributions heading within your submission after the Acknowledgements section. The information you give on submission will then show under the Author Contributions heading later at the proofing stage.
Source ↗Publisher website ·- Data availability Data availability
The Journal is committed to facilitating openness, transparency and reproducibility of research, and has the following research data sharing policy. For more information, including FAQs please visit the Sage Research Data policy pages. Subject to appropriate ethical and legal considerations, authors are encouraged to: Share your research data in a relevant public data repository Include a data ava…
Source ↗Publisher website ·- Publication ethics Ethical considerations
Member of COPE Model summary
Please include your ethics approval statements under this heading, even if you have already included ethics approval information in your methods section. If ethical approval was not required, you need to explicitly state this. All papers reporting studies involving human participants, human data or human tissue must state that the relevant Ethics Committee or Institutional Review Board approved th…
Source ↗Publisher website ·- Open access Publishing fees and open access
Clinical Medicine Insights: Oncology is an open access, peer-reviewed journal. All accepted articles are made freely available online immediately upon publication, are published under a Creative Commons license, and hosted online in perpetuity. If, after peer review, your manuscript is accepted for publication, a one-time article processing charge (APC) is payable to cover the cost of publishing, …
Source ↗Publisher website ·- Peer review Peer review policy
Single anonymized peer review Model summary
The following summary describes the peer review process for this journal: Identity transparency: Single-anonymized Reviewer interacts with: Editor Review information published: None Your manuscript will undergo an initial evaluation. If it does not conform to the requirements laid out in these guidelines, it will be returned to you for amendments prior to peer review. Manuscripts may be desk rejec…
Source ↗Publisher website ·- Plagiarism Plagiarism
The journal and Sage take issues of copyright infringement, plagiarism or other breaches of best practice in publication very seriously. Please read Sage's complete policy on plagiarism and the actions we may take.
Source ↗Publisher website ·- Preprints Preprints
The journal will consider submissions of manuscripts that have been posted on preprint servers. Please enter the preprint DOI in the designated field when submitting your manuscript. We advise that you inform the Journal Editorial office about your posted preprint at submission. Note that you should not post an updated version of your manuscript on a preprint server while it is being peer reviewed…
Source ↗Publisher website ·- Trial registration / reporting guidelines Clinical trial registration
The journal endorses the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first participant enrollment. However, consistent with the AllTrials campaign, retrospectively registered trials will be considered if the justification for late registration is acceptable. The trial registry name and URL, and registration number must be …
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Libertas Academica
- Country or region
- ENGLAND
- Language
- English
- ISSN
- 1179-5549
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗LetPub
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Clinical Medicine Insights-Oncology
What CAS zone is Clinical Medicine Insights-Oncology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Clinical Medicine Insights-Oncology is in Zone 4 of Medicine, and in Zone 4 of the minor category Oncology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Clinical Medicine Insights-Oncology?
The latest impact factor listed by LetPub is 2.58; CiteScore 3.5, h-index 43.
How long does peer review take at Clinical Medicine Insights-Oncology?
Based on the dates recorded on 97 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 147 days (interquartile range 122–190 days); authors report an average review time of about 8 weeks; the journal's website gives an acceptance rate of 12.2%. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Clinical Medicine Insights-Oncology?
According to the journal's author guidelines: Reference style: AMA; Suggested reviewers: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Clinical Medicine Insights-Oncology based?
Of the 168 board members whose country the journal's board page names, 35 (about 21%) are in mainland China; the countries named most often are United States (46), Mainland China (35) and Italy (23). Counted from the institutions listed on the board page; for reference only.
Which databases index Clinical Medicine Insights-Oncology?
According to LetPub and DOAJ records, Clinical Medicine Insights-Oncology is indexed in SCIE, Scopus and DOAJ.
Is Clinical Medicine Insights-Oncology open access, and what is the APC?
Clinical Medicine Insights-Oncology is a fully open-access journal. APC about USD 2,650.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .